These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 23469801

  • 1. [Efficacy and safety of rituximab therapy for refractory/relapsing thrombotic thrombocytopenic purpura].
    Cui J, Zhu TN, Zou N, Chen M, Zhao YQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):116-20. PubMed ID: 23469801
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: results of a Spanish multicenter study.
    Rubia J, Moscardó F, Gómez MJ, Guardia R, Rodríguez P, Sebrango A, Zamora C, Debén G, Goterris R, López R, Peña F, Pujol M, Vidaller A, Río-Garma JD, Sanz MA, Grupo Español de Aféresis (GEA).
    Transfus Apher Sci; 2010 Dec; 43(3):299-303. PubMed ID: 20934383
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.
    Froissart A, Buffet M, Veyradier A, Poullin P, Provôt F, Malot S, Schwarzinger M, Galicier L, Vanhille P, Vernant JP, Bordessoule D, Guidet B, Azoulay E, Mariotte E, Rondeau E, Mira JP, Wynckel A, Clabault K, Choukroun G, Presne C, Pourrat J, Hamidou M, Coppo P, French Thrombotic Microangiopathies Reference Center.
    Crit Care Med; 2012 Jan; 40(1):104-11. PubMed ID: 21926591
    [Abstract] [Full Text] [Related]

  • 4. A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab.
    Clark WF, Rock G, Barth D, Arnold DM, Webert KE, Yenson PR, Kelton JG, Li L, Foley SR, members of Canadian Apheresis Group.
    Br J Haematol; 2015 Jul; 170(2):208-17. PubMed ID: 25855259
    [Abstract] [Full Text] [Related]

  • 5. Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura.
    Bhagirath VC, Kelton JG, Moore J, Arnold DM.
    Transfusion; 2012 Dec; 52(12):2517-23. PubMed ID: 22486316
    [Abstract] [Full Text] [Related]

  • 6. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
    Koulova L, Alexandrescu D, Dutcher JP, O'Boyle KP, Eapen S, Wiernik PH.
    Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
    [Abstract] [Full Text] [Related]

  • 7. Long-term response to rituximab in patients with relapsing thrombotic thrombocytopenic purpura.
    Stein GY, Blickstein D, Orlin J, Sarig G, Inbal A.
    Isr Med Assoc J; 2011 Jul; 13(7):398-401. PubMed ID: 21838180
    [Abstract] [Full Text] [Related]

  • 8. Successful repeat therapy with rituximab for relapsed thrombotic thrombocytopenic purpura.
    Patino W, Sarode R.
    J Clin Apher; 2007 Feb; 22(1):17-20. PubMed ID: 17285618
    [Abstract] [Full Text] [Related]

  • 9. Long-term remission of recurrent thrombotic thrombocytopenic purpura (TTP) after Rituximab in children and young adults.
    Wieland I, Kentouche K, Jentzsch M, Lothschütz D, Graf N, Sykora KW.
    Pediatr Blood Cancer; 2015 May; 62(5):823-9. PubMed ID: 25623397
    [Abstract] [Full Text] [Related]

  • 10. Rituximab therapy to prevent relapse in chronic relapsing thrombotic thrombocytopenic purpura (TTP) in a child.
    Jayabose S, Dunbar J, Nowicki TS, Tugal O, Ozkaynak MF, Sandoval C.
    Pediatr Hematol Oncol; 2011 Mar; 28(2):167-72. PubMed ID: 20469972
    [Abstract] [Full Text] [Related]

  • 11. [Rituximab for managing refractory thrombotic thrombocytopenic purpura: a report of three cases].
    Yamanouchi J, Hato T, Miyoshi K, Kobayashi S, Azuma T, Hasegawa H, Yasukawa M.
    Rinsho Ketsueki; 2013 Feb; 54(2):205-9. PubMed ID: 23470828
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab.
    Chemnitz JM, Uener J, Hallek M, Scheid C.
    Ann Hematol; 2010 Oct; 89(10):1029-33. PubMed ID: 20422413
    [Abstract] [Full Text] [Related]

  • 13. Rituximab provided long-term remission in a patient with refractory relapsing thrombotic thrombocytopenic purpura.
    Kosugi S, Matsumoto M, Ohtani Y, Take H, Ishizashi H, Fujimura Y, Kuyama J.
    Int J Hematol; 2005 Jun; 81(5):433-6. PubMed ID: 16158827
    [Abstract] [Full Text] [Related]

  • 14. Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: a report of four cases and a systematic review of the literature.
    Elliott MA, Heit JA, Pruthi RK, Gastineau DA, Winters JL, Hook CC.
    Eur J Haematol; 2009 Oct; 83(4):365-72. PubMed ID: 19508684
    [Abstract] [Full Text] [Related]

  • 15. Clinical biological remission induced by rituximab in acute refractory chronic relapsing TTP.
    Lombardi AM, de Marinis GB, Scandellari R, Magalini F, Sansoni P, Ballerini PF, Vettore S, Candeo N, Marson P, De Silvestro G, Fabris F.
    Thromb Res; 2010 Aug; 126(2):e154-6. PubMed ID: 20193960
    [No Abstract] [Full Text] [Related]

  • 16. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C, Reu FJ, Ho AD, Hensel M.
    Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
    [Abstract] [Full Text] [Related]

  • 17. [Clinical efficacy of lower dose rituximab for chronic refractory immune thrombocytopenic purpura].
    Li Y, Wang XM, Mao M, Zhang XY, Fu L, Ai HM, Zhang LX.
    Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):204-6. PubMed ID: 22781608
    [Abstract] [Full Text] [Related]

  • 18. Relapses of thrombotic thrombocytopenic purpura after treatment with rituximab.
    Goyal J, Adamski J, Lima JL, Marques MB.
    J Clin Apher; 2013 Dec; 28(6):390-4. PubMed ID: 23857472
    [Abstract] [Full Text] [Related]

  • 19. Rituximab in the treatment of relapsed thrombotic thrombocytopenic purpura.
    Reddy PS, Deauna-Limayo D, Cook JD, Ganguly SS, Blecke C, Bodensteiner DC, Skikne BS, Sahud MA.
    Ann Hematol; 2005 Apr; 84(4):232-5. PubMed ID: 15517266
    [Abstract] [Full Text] [Related]

  • 20. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis.
    Garcia-Chavez J, Majluf-Cruz A, Montiel-Cervantes L, Esparza MG, Vela-Ojeda J, Mexican Hematology Study Group.
    Ann Hematol; 2007 Dec; 86(12):871-7. PubMed ID: 17874322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.